Form EFFECT Acurx Pharmaceuticals,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 29, 2025 4:01 P.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Acurx Pharmaceuticals Takes Its Antibiotics Story Global Through a 12-Month Series with New to The Street
- Crypto News: Remittix Opens PayFi to 1,000 Holders as Bitcoin Price Prediction Explodes to $200,000 and Solana’s 200ms Upgrade Fuels a $300 SOL Target
- Ethereum and Arbitrum Price Prediction: ARB Rebounds as Remittix Offers a Completely Different Growth Story
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share